Another study of combined treatment with neutralizing antibodies against IL-10 and CAR-T in 38 patients with MSS liver metastatic CRC showed that IL-10 increased CEA-specific CAR-T cell activation and promoted CAR-T mediated tumor cell death, inducing nearly 70% apoptosis in tumor biopsies (66). The gene discussed is IL10; the disease is medical procedure.